Indiana health system withdraws merger application after regulator pushback
Union Health said it would submit a new Certificate of Public Advantage application to try to acquire Terre Haute Regional Hospital.
Nearly a quarter of Americans are underinsured: report
Twenty-three percent of working-age adults with health insurance face high out-of-pocket costs that make it difficult to afford care, according to a survey by the Commonwealth Fund.
HIPAA audits not effective at improving cybersecurity: OIG
The HHS’ Office for Civil Rights’ audit program was too narrow in scope to effectively assess data protections and reduce cyber risks in the healthcare sector, according to the report.
Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs
About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration allows the rule to go into effect — at the cost of $40 billion to federal and state governments.
Sanofi joins J&J, Eli Lilly in proposing 340B rebate model
Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top 10 drugs in global sales — early next year. It’s unclear how regulators will react.
Healthcare costs are going to increase by double digits — again, per WTW
While some factors are out of employers’ control, it’s up to companies to balance rising costs with budget expectations, experts said.
CHS to sell Florida-based ShorePoint Health System
The $265 million deal with Advent Health is expected to close early next year.
AI could be ‘transformational’ for payers, experts say
Insurers could save 20% in administrative costs and 10% in medical costs by harnessing the technology, experts said during a panel hosted by Healthcare Dive last week.
CMS ordered to recalculate UnitedHealthcare’s 2025 MA stars
A Texas federal judge has sided with UnitedHealthcare in determining regulators messed up calculating its Medicare Advantage quality scores for next year. The decision could have big implications for similar pending cases.
Johns Hopkins surgeon Makary is Trump’s pick to lead FDA
A prolific medical research and author, Martin Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.